Skip to Content
COVID-19 Response and Update

We make healthy possible

 

Leading forward

Our leaders talk about how Amneal has diversified beyond generics to deliver value in complex retail generics, biosimilars, injectables, specialty and international.

Watch video Voices of Leadership

As of November 7, 2023, Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).

 

Our products

Our broad portfolio of approximately 270 generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.

Generics Products Specialty Products Biosciences Products Expanded Access Policy

 
  • Touching lives

  • Our family works for yours.
    See how we're making healthy possible.
    Read More >

 

Press releases

We’re committed to delivering value. Learn more about the meaningful difference we’re making for people and healthcare.

 

See other news
Our Culture

Our culture

Our culture is driven by actions that inspire us to Rise, Lead and Succeed – for patients and their families.

 

See our culture in action

Join our family

Apply your passion and talents to help us touch more lives.

 

See our opportunities